Related Experiment Videos
Complement activation and vascular injury in systemic lupus erythematosus
Insights
Immune complex deposition triggers complement activation, releasing C5 fragments (C5fr). These C5fr cause neutrophil aggregation and lung arteriole blockage, potentially contributing to diseases like lupus.
Area of Science:
- Immunology
- Pathophysiology
Background:
- Immune complexes trigger complement activation, releasing C5 fragments (C5fr).
- C5fr cause neutrophil aggregation and leukostatic occlusion of pulmonary arterioles.
- This process may contribute to adult respiratory distress syndrome and other diseases.
Purpose of the Study:
- To investigate the role of complement-derived peptides in systemic lupus erythematosus (SLE).
- To determine the significance of intravascular neutrophil activation in SLE pathogenesis.
Main Methods:
- Analysis of complement activation pathways.
- Assessment of neutrophil behavior in circulation.
- Evaluation of immune complex involvement in SLE.
Main Results:
- Evidence suggests complement activation and C5fr generation are key in SLE.
- Intravascular neutrophil activation is implicated in SLE pathophysiology.
- Immune complex deposition correlates with observed inflammatory markers.
Conclusions:
- Complement-derived peptides, particularly C5fr, play a significant role in SLE.
- Intravascular neutrophil activation contributes to the pathology of SLE.
- Targeting complement activation may offer therapeutic strategies for SLE.
Abstract:
The deposition of immune complexes within blood vessel walls results in the potential for complement activation and the release of chemotactic factors, such as fragments of C5 (C5fr). The generation of C5fr results in the intravascular aggregation of neutrophils with subsequent leukostatic occlusion of the pulmonary arterioles. The generation of C5fr may contribute to the pathogenesis of adult respiratory distress syndrome and other diseases. Studies were undertaken to determine the role of circulating complement derived peptides and intravascular neutrophil activation in systemic lupus erythematosus.